Biomarkers for Germ cell tumor

1. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]